Vijay Pande, a general companion of Andreessen Horowitz establishing the firm’s health strategy A16Z Bio + Office has partnered that he ran out of his paper.
Since the 2014 establishment, the A16Z Bio + Health has raised four funds around $ 3 billion each, including a $ 1.5 billion funds of 2022. However, it currently seeks to be very small $ 750 million fifth fundsReported on the Wall Street Journal. In January, the A16Z Bio + Health announced that it would be in charge a $ 500 million biotech fund funded by the giant pharmacist Eli Lilly.
The A16Z Bio + Health is backing Digital Health Startups and AI intersection companies, computation, and biology.
Pande investment includes devoted health, an individual planning medical planning; Health function, a personal lab test test; And freenome, a firm intending to know cancer by blood drawings. Before participating in Andreessen Horowitz, Pande was a professor of chemistry, structural biology, and computer science at Stanford University.
The rest of the A16z Bio + Health team is Jorge Conde, Julie Yoo, and Vineyard Agarwala.
